Cardiol Therapeutics Ratios (2021-2022) | CRDL

Ratios Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022
Profitability
EBITDA Margin 99.22%102.14%97.50%47.78%91.48%70.29%60.30%
FCF Margin 78.89%94.55%62.83%30.51%106.40%27.80%12.81%
Efficiency
Inventory Average 0.00B0.00B
Assets Average 0.03B0.05B0.07B0.07B0.06B
Equity Average 0.07B0.08B0.07B56,468.18B56,468.21B0.11B
Invested Capital 0.05B0.09B0.07B0.06B112,936.31B0.12B0.11B
Asset Utilization Ratio -0.65-0.42-0.49-0.64
Leverage & Solvency
Debt to Equity 0.090.000.030.01
Debt Ratio 0.080.050.050.03
Equity Ratio 2.862.830.870.00B1.932.15
Valuation
Enterprise Value -0.00B-0.03B0.17B0.01B0.10B0.09B0.08B
Market Capitalization 0.18B0.08B0.09B0.08B0.06B